<p>Date: 2008-06-05</p><p>Level: Master Thesis in Business Administration, 15 ECTS</p><p>Authors: Amina Ahmed Ibrahim Beatrice Yola Konlaan Carol Nakajugo Basudde</p><p>Tutor: Sigvard Herber</p><p>Title: Are competitors ready to take on a deregulated Apoteket AB? Problem: With the oncoming deregulation of the monopoly, Apoteket AB appears to have a competitive advantage over incoming competition therefore the problem is to find out:</p><p> What competitive advantage Apoteket AB has over its competitors.</p><p> If the competitors have the tools to successfully compete with Apoteket AB.</p><p>Purpose: The purpose of this thesis is to find out whether competitors in Sweden are able to compete successfully with Apoteket AB for the market of non prescription medicine.</p><p>Method: Qualitative and quantitative methods have been used in this thesis. In order to achieve the desired result of this research it is appropriate to choose this approach since it enables the researcher to be able to explore all areas of the subject at hand and also give an in-depth discussion and analysis.</p><p>Conclusion: Apoteket AB has several competitive advantages over its competitors. It has a strong brand name that is known and trusted by customers. While all three competing companies see themselves as complements to Apoteket AB, we think that the competitors have what it takes to successfully compete with Apoteket. Judging from previous cases such as Norway and Denmark which showed different outcomes of deregulation in the retail pharmaceutical industry, the competitors in both cases have not been on the losing side. Supermarkets, petrol stations and grocery stores in Denmark and Norway were also competing with their respective pharmacies based mainly on price, accessibility and convenience. In conclusion this is an indication that the competitors in Sweden have more than enough tools to successfully compete with Apoteket AB.</p><p>Keywords: Deregulation, Pharmaceutical retail, Apoteket AB, Monopoly, Competition.</p> / <p>Datum: 2008-06-05</p><p>Nivå: Magister Uppsats i Företagsekonomi, 15 Högskolepoäng Författare: Amina Ahmed Ibrahim Beatrice Yola Konlaan Carol Nakajugo Basudde</p><p>Handledare: Sigvard Herber</p><p>Titel: Är konkurrenter beredda att konkurrera med Apoteket AB i en avreglerad marknad?</p><p>Problem: I samband med den kommande avregleringen av monopolet, Apoteket AB verkar ha konkurrensfördel gentemot konkurrenterna. Problemformuleringen lyder:</p><p> Vilka konkurrensfördelar har Apoteket AB över sina konkurrenter?</p><p> Har konkurrenterna de rätta verktygen för att framgångsrikt konkurrera med Apoteket AB?</p><p>Syfte: Uppsatsens syfte är att ta reda på om konkurrenterna i Sverige kan framgångsrikt konkurrera med Apoteket AB i den receptfria marknaden.</p><p>Metod: En kvalitativ och kvantitativ metod har använts i denna uppsats. För att uppnå det önskade resultat är det nödvändigt att använda sig av både en kvalitativ och kvantitativ metod, dels för att utförligt kunna utforska ämnet och ge en djupgående diskussion och analys.</p><p>Slutsats: Apoteket AB har en mängd konkurrensfördelar över sina konkurrenter. Företaget har ett starkt märke som kunderna känner till och litar på. De tre konkurrerande företag ser sig själva som ett komplement till Apoteket AB dock anser vi att konkurrenterna har vad som krävs för att framgångsrikt kunna konkurrera med Apoteket. Apotekets avreglering i Norge och Danmark har visat olika resultat, däremot har inte konkurrenterna i båda fall inte varit på den förlorande sidan. Matbutiker och bensin stationer i Danmark och Norge har konkurrerat med huvudsakligen pris, bekvämlighet och tillgänglighet med sina respektive Apotek. Detta är en indikation på att konkurrenterna i Sverige har tillräckligt med verktyg för att framgångsrikt kunna konkurrera med Apoteket AB.</p><p>Nyckelord: Avreglering, Apoteket AB, Monopol, Konkurrens.</p>

Date: 2008-06-05 Level: Master Thesis in Business Administration, 15 ECTS Authors: Amina Ahmed Ibrahim Beatrice Yola Konlaan Carol Nakajugo Basudde Tutor: Sigvard Herber Title: Are competitors ready to take on a deregulated Apoteket AB? Problem: With the oncoming deregulation of the monopoly, Apoteket AB appears to have a competitive advantage over incoming competition therefore the problem is to find out:  What competitive advantage Apoteket AB has over its competitors.  If the competitors have the tools to successfully compete with Apoteket AB. Purpose: The purpose of this thesis is to find out whether competitors in Sweden are able to compete successfully with Apoteket AB for the market of non prescription medicine. Method: Qualitative and quantitative methods have been used in this thesis. In order to achieve the desired result of this research it is appropriate to choose this approach since it enables the researcher to be able to explore all areas of the subject at hand and also give an in-depth discussion and analysis. Conclusion: Apoteket AB has several competitive advantages over its competitors. It has a strong brand name that is known and trusted by customers. While all three competing companies see themselves as complements to Apoteket AB, we think that the competitors have what it takes to successfully compete with Apoteket. Judging from previous cases such as Norway and Denmark which showed different outcomes of deregulation in the retail pharmaceutical industry, the competitors in both cases have not been on the losing side. Supermarkets, petrol stations and grocery stores in Denmark and Norway were also competing with their respective pharmacies based mainly on price, accessibility and convenience. In conclusion this is an indication that the competitors in Sweden have more than enough tools to successfully compete with Apoteket AB. Keywords: Deregulation, Pharmaceutical retail, Apoteket AB, Monopoly, Competition. / Datum: 2008-06-05 Nivå: Magister Uppsats i Företagsekonomi, 15 Högskolepoäng Författare: Amina Ahmed Ibrahim Beatrice Yola Konlaan Carol Nakajugo Basudde Handledare: Sigvard Herber Titel: Är konkurrenter beredda att konkurrera med Apoteket AB i en avreglerad marknad? Problem: I samband med den kommande avregleringen av monopolet, Apoteket AB verkar ha konkurrensfördel gentemot konkurrenterna. Problemformuleringen lyder:  Vilka konkurrensfördelar har Apoteket AB över sina konkurrenter?  Har konkurrenterna de rätta verktygen för att framgångsrikt konkurrera med Apoteket AB? Syfte: Uppsatsens syfte är att ta reda på om konkurrenterna i Sverige kan framgångsrikt konkurrera med Apoteket AB i den receptfria marknaden. Metod: En kvalitativ och kvantitativ metod har använts i denna uppsats. För att uppnå det önskade resultat är det nödvändigt att använda sig av både en kvalitativ och kvantitativ metod, dels för att utförligt kunna utforska ämnet och ge en djupgående diskussion och analys. Slutsats: Apoteket AB har en mängd konkurrensfördelar över sina konkurrenter. Företaget har ett starkt märke som kunderna känner till och litar på. De tre konkurrerande företag ser sig själva som ett komplement till Apoteket AB dock anser vi att konkurrenterna har vad som krävs för att framgångsrikt kunna konkurrera med Apoteket. Apotekets avreglering i Norge och Danmark har visat olika resultat, däremot har inte konkurrenterna i båda fall inte varit på den förlorande sidan. Matbutiker och bensin stationer i Danmark och Norge har konkurrerat med huvudsakligen pris, bekvämlighet och tillgänglighet med sina respektive Apotek. Detta är en indikation på att konkurrenterna i Sverige har tillräckligt med verktyg för att framgångsrikt kunna konkurrera med Apoteket AB. Nyckelord: Avreglering, Apoteket AB, Monopol, Konkurrens.

Made available in DSpace on 2016-03-15T19:26:33Z (GMT). No. of bitstreams: 1 BIANCA_BONASSI_ADM.pdf: 815574 bytes, checksum: 83a2aaee5bc1b69056da2f4fa2fe6180 (MD5) Previous issue date: 2006-08-23 / The present study is a exploratory research which refers to the possibility of pharmacies and drugstores establish a partnership in order to reach sustainable competitive advantage within the region of Bragança Paulista, São Paulo s countryside. Brazil is the 8th country in the medication market where 80% of the businesses correspond to the medication´ selling, according to the study accomplished by the BNDES Sectorial Management of Commerce and Services. Nowadays, there are about 56.000 pharmacies and drugstores which fit in one of the following structures: a) independents; b) groups; c) co-operatives; and d) franchises. The theoretical reference follows explaining the context, the concept, the development and the sustainable competitive advantage. To this part of the research, the theoretical investigation was based on Ansoff (1977), Porter (1986), Mintzberg (1994), Ohmae (1998), Hill and Jones (1998), Aaker (2001), Barney (2002) and Grant (2002). The theoretical reference also presents the partnership strategy as an alternative to obtain the competitive advantage. To defend this idea the following theorists were consulted: Hill and Jones (1998), Inkpen (2001), Thompson and Strickland (2001) and Barney (2002). The research problem that guided this study was to identify the relation between the strategic partnership and the sustainable competitive advantage in pharmacies and drugstores. A quality fieldwork was conducted with ten pharmacies and drugstores managers in the cities of Bragança Paulista and Atibaia. The main purpose was to verify, through the retailers opinion, if there is a sustainable competitive advantage in forming strategic partnerships. The collected data was interpreted by the contents analysis developed by Bardin (1977). It was verified that the researched pharmacies and drugstores used seven types of strategic partnerships (franchises, co-operatives, exclusive supplier, own covenants, outsourced covenants, partnerships between manipulation pharmacies and drugstores and, at last, partnerships with other pharmacies and drugstores to share the purchase). When comparing the fieldwork collected data to the researched theoretical reference in the present study, it concludes that partnerships promote competitive advantage to the pharmaceutical retail studied. / O presente estudo é uma pesquisa de caráter exploratório que se refere à possibilidade de farmácias e drogarias desenvolverem alianças, de maneira a alcançar vantagem competitiva sustentável na região de Bragança Paulista, interior do estado de São Paulo. O Brasil é o 8o país no mercado de medicamentos, onde 80% dos negócios do setor correspondem à venda de medicamentos, conforme estudo realizado pela Gerência Setorial de Comércio e Serviços do BNDES. Atualmente, existem em torno de 56.000 farmácias e drogarias que se encaixam em uma das seguintes estruturas: a) independentes; b) redes; c) associativismo (cooperativas); e d) franquias. O referencial teórico segue expondo o contexto, o conceito, o desenvolvimento e a sustentação da vantagem competitiva. Neste sentido, compuseram esta parte do referencial teórico Ansoff (1977), Porter (1986), Mintzberg (1994), Ohmae (1998), Hill e Jones (1998), Aaker (2001), Barney (2002) e Grant (2002). O referencial teórico também apresenta a aliança estratégica como alternativa para obtenção da vantagem competitiva; defendem esta idéia Hill e Jones (1998), Inkpen (2001), Thompson e Strickland (2001) e Barney (2002). O problema de pesquisa que orientou este estudo foi identificar qual a relação entre aliança estratégica e vantagem competitiva sustentável em farmácias e drogarias. Foi realizada uma pesquisa de campo qualitativa com dez gestores de farmácias e drogarias nas cidades de Bragança Paulista e Atibaia. O objetivo geral foi o de verificar, por meio da opinião do varejista, se existe vantagem competitiva sustentável ao formar alianças estratégicas. Os dados coletados foram interpretados por meio da análise de conteúdo desenvolvida por Bardin (1977). Verificou-se que as farmácias e drogarias pesquisadas utilizam sete tipos de alianças estratégicas (franquias, cooperativas, fornecedores exclusivos, convênios próprios, convênios terceirizados, alianças entre farmácias de manipulação e drogarias e por fim, alianças com outras farmácias e drogarias para compartilhar compras). Ao confrontar os dados coletados na pesquisa de campo com o referencial teórico levantado por este estudo, concluiu-se que formar alianças gera vantagem competitiva para o varejo farmacêutico estudado.

Submitted by Adriana Alves Rodrigues (aalves@espm.br) on 2017-11-21T13:30:12Z No. of bitstreams: 1 Teresa_Cristina_Alves_Charotta.pdf: 2804681 bytes, checksum: aa9f030caaa3032e561644d098e3ca4c (MD5) / Approved for entry into archive by Adriana Alves Rodrigues (aalves@espm.br) on 2017-11-21T13:30:49Z (GMT) No. of bitstreams: 1 Teresa_Cristina_Alves_Charotta.pdf: 2804681 bytes, checksum: aa9f030caaa3032e561644d098e3ca4c (MD5) / Approved for entry into archive by Ana Cristina Ropero (ana@espm.br) on 2017-11-22T12:58:36Z (GMT) No. of bitstreams: 1 Teresa_Cristina_Alves_Charotta.pdf: 2804681 bytes, checksum: aa9f030caaa3032e561644d098e3ca4c (MD5) / Made available in DSpace on 2017-11-22T12:58:52Z (GMT). No. of bitstreams: 1 Teresa_Cristina_Alves_Charotta.pdf: 2804681 bytes, checksum: aa9f030caaa3032e561644d098e3ca4c (MD5) Previous issue date: 2017-05-19 / The research question that guided this dissertation was how does the management of stakeholders contribute to the implementation of innovations in services? Thus, the general objective of the dissertation was to understand how the positioning and the relationship of the stakeholders guide the strategies of implementation of innovations in services. In order to do so, it was analyzed, as research object, the implementation of innovation in services in the Brazilian pharmaceutical retail. A descriptive exploratory qualitative research was conducted with a single case study method with intracausal analysis of the Pague Menos Pharmacies Network, with structured field interviews and the Focus Group. Next, it was categorized for Stakeholder analysis: Strategy of Positioning and Relationship Approach to carry out the data collection. In the first. In the data collection stage, field interviews were conducted with highlevel hierarchical stakeholders, CEOs, CIOs and specialized managers in the pharmaceutical and health market. A Focus Group was held with consumers who attend pharmacies and drugstores, but are unaware of what differentiated pharmaceutical services are. Participation in the Abrafarma Future Trends 2016 Event provided observational interviews with entity and government (Anvisa). The data collection period occurred between August and November 2016. As an academic contribution, what was sought in this study was to bring the Stakeholders Theory applied to innovation, service innovation and business model innovation to respond as the stakeholder (Freeman, 1984) and strategic relationship matrix (Frooman, 1999, 2002) that identified the interests, the potential of Power and threat potential of stakeholders. The study was able to demonstrate the strategy adopted by stakeholders the retail network, whether it is supported, partially supported or unsupported. As a managerial contribution, we sought to answer the questions Carrol and Buchholtz (2000) establish for an organization to orient itself in the development of actions with stakeholders. / A questão de pesquisa que guiou essa dissertação foi como a gestão dos stakeholders contribui na implementação de inovações em serviços? Assim o objetivo geral da dissertação foi compreender como o posicionamento e o relacionamento dos stakeholders direcionam as estratégias de implementação de inovações em serviços. Para tanto, foi analisada, como objeto de pesquisa, a implementação de inovação em serviços no varejo farmacêutico brasileiro. Foi realizada uma pesquisa qualitativa exploratória descritiva com método estudo de caso único com análise intracaso da Rede de Farmácias Pague Menos, com entrevistas de campo estruturadas e Focus Group. Em seguida, foi categorizada para análise em Stakeholders: Estratégia de Posicionamento e Abordagem de Relacionamento para realização da coleta de dados. Na 1ª. etapa da coleta de dados foram realizadas entrevistas de campo com stakeholders dirigentes de alto nível hierárquico, CEO, CIO e gestores especialistas atuantes no mercado farmacêutico e da Saúde. Na 2ª. etapa foi realizado um Focus Group com consumidores que frequentam farmácias e drogarias, mas desconhecem o que são serviços farmacêuticos diferenciados. A participação no Evento Abrafarma Future Trends 2016 proporcionou a realização de entrevistas observacionais de entidade e Governo (Anvisa). O período da coleta de dados aconteceu entre os meses de agosto e novembro de 2016. Como contribuição acadêmica o que se buscou nesse estudo foi trazer a Teoria dos Stakeholders aplicada à inovação, inovação em serviços e inovação de modelo de negócio para responder como o stakeholder se comporta perante a implementação de inovação em serviços no varejo farmacêutico brasileiro, o qual foi baseado na matriz estratégica de posicionamento (Freeman, 1984) e matriz estratégica de abordagem de relacionamento (Frooman, 1999, 2002) que identificou os interesses, o potencial de poder e potencial de ameaças exercidas pelos stakeholders. O estudo conseguiu demonstrar a estratégia adotada pelos stakeholders e a rede varejista, se é suportada, parcialmente suportada ou não suportada. Como contribuição gerencial buscou-se responder as questões que Carrol e Buchholtz (2000) estabelecem para uma organização se orientar no desenvolvimento de ações com os stakeholders.